Literature DB >> 12676980

A three-dimensional model of Suppressor Of Cytokine Signalling 1 (SOCS-1).

Fabrizio Giordanetto1, Romano T Kroemer.   

Abstract

Suppressor Of Cytokine Signalling 1 (SOCS-1) is one of the proteins responsible for the negative regulation of the JAK-STAT pathway triggered by many cytokines. This important inhibition involves complex formation between SOCS-1 and JAK2, which requires particular structural domains (KIR, ESS and SH2) on SOCS-1. A three-dimensional theoretical model of SOCS-1 is presented here. The model was generated by the application of different modelling techniques, including threading, structure-based modelling, surface analysis and protein docking. The structure accounts for the interactions between SOCS-1 and two other key proteins in the JAK-STAT pathway, namely JAK2 and Elongin BC. The proposed model for the interaction between SOCS-1 and JAK2 suggests that the SOCS-1 suppress the kinase activity of JAK2 by obstructing the catalytic groove of the tyrosine kinase. Subsequent interaction of the JAK-SOCS complex with Elongin BC was also modelled. A sequence and structural comparison between the SH2 domain of SOCS-1 and the SH2 domains of other proteins highlights key residues that could be responsible for SOCS-1 specificity. Currently available mutational data are evaluated. The results are consistent with the experimental data and they provide deeper insights into the inhibitory function of SOCS-1 at a molecular level.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12676980     DOI: 10.1093/proeng/gzg015

Source DB:  PubMed          Journal:  Protein Eng        ISSN: 0269-2139


  18 in total

Review 1.  Negative regulation of cytokine signaling.

Authors:  Akihiko Yoshimura
Journal:  Clin Rev Allergy Immunol       Date:  2005-06       Impact factor: 8.667

2.  Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.

Authors:  Rebecca A R Piganis; Nicole A De Weerd; Jodee A Gould; Christian W Schindler; Ashley Mansell; Sandra E Nicholson; Paul J Hertzog
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

3.  SOCS1 abrogates IFN's antiviral effect on hepatitis C virus replication.

Authors:  Run-Xuan Shao; Leiliang Zhang; Zhi Hong; Kaku Goto; Du Cheng; Wen-Chi Chen; Nikolaus Jilg; Kattareeya Kumthip; Dahlene N Fusco; Lee F Peng; Raymond T Chung
Journal:  Antiviral Res       Date:  2012-12-10       Impact factor: 5.970

Review 4.  Janus kinase 3: the controller and the controlled.

Authors:  Wei Wu; Xiao-Hong Sun
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2011-11-29       Impact factor: 3.848

5.  A mechanism underlying NOTCH-induced and ubiquitin-mediated JAK3 degradation.

Authors:  Wei Wu; Xiao-Hong Sun
Journal:  J Biol Chem       Date:  2011-10-03       Impact factor: 5.157

6.  The C-terminus of CIS defines its interaction pattern.

Authors:  Delphine Lavens; Peter Ulrichts; Dominiek Catteeuw; Kris Gevaert; Joël Vandekerckhove; Frank Peelman; Sven Eyckerman; Jan Tavernier
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

7.  Extended JAK activation and delayed STAT1 dephosphorylation contribute to the distinct signaling profile of CNS neurons exposed to interferon-gamma.

Authors:  Michael A Podolsky; Andreas C Solomos; Lisa C Durso; Stephanie M Evans; Glenn F Rall; R Wesley Rose
Journal:  J Neuroimmunol       Date:  2012-07-04       Impact factor: 3.478

8.  Crystal structure of the SOCS2-elongin C-elongin B complex defines a prototypical SOCS box ubiquitin ligase.

Authors:  Alex N Bullock; Judit E Debreczeni; Aled M Edwards; Michael Sundström; Stefan Knapp
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-04       Impact factor: 11.205

9.  Leptin signaling: A key pathway in immune responses.

Authors:  Claudio Procaccini; Elaine V Lourenco; Giuseppe Matarese; Antonio La Cava
Journal:  Curr Signal Transduct Ther       Date:  2009-01-01

10.  Intracellular delivery of a cell-penetrating SOCS1 that targets IFN-gamma signaling.

Authors:  Antonio DiGiandomenico; Lukasz S Wylezinski; Jacek Hawiger
Journal:  Sci Signal       Date:  2009-07-21       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.